NFKB1 and mesothelioma: Therefore, the NF-κB pathway must be an important molecular target in the progression of mesothelioma, and IMD-0354 has a potential role in anti-mesothelioma therapy as well as prevention of mesothelioma formation in patients seriously exposed to asbestos.